MAIA Biotechnology, Inc. is a pioneering company in the field of cancer treatment, developing innovative targeted therapies and immuno-oncology treatments to improve and extend the lives of cancer patients worldwide.

MAIA Biotechnology, Inc. has gained recognition at the prestigious ASCO 2025 Annual Meeting, highlighting its commitment to advancing cancer treatment through innovative drug development.